Home / Tag Archives: NASDAQ: BLRX

Tag Archives: NASDAQ: BLRX

Stocks On The Run: BioLineRx Ltd. (NASDAQ/TASE: BLRX)

BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, declared recently that Genentech, a member of the Roche Group, has begind a Phase 1b/2 study for BL-8040 in combination with atezolizumab (TECENTRIQ®), Genentech’s anti-PDL1 cancer immunotherapy agent, evaluating the combination in metastatic pancreatic ductal adenocarcinoma. Up …

Read More »